Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • Big Wins
  • About OHRP
  • Regulations, Policy & Guidance
  • Education & Outreach
  • Compliance & Reporting
  • News & Events
  • Register IRBs & Obtain FWAs
  • SACHRP Committee
  • International
Breadcrumb
  1. HHS
  2. OHRP
  3. Education & Outreach
  4. Exploratory Workshop
  5. 2023 OHRP Exploratory Workshop
  6. Exploring the Ethical and Practical Considerations of Psychedelics Research
  • About Research Participation
    • Informational Videos
    • Questions to Ask
    • Protecting Research Volunteers
      • Why Have Regulations to Protect Research Participants?
      • What Regulations Protect Research Participants?
      • Who Oversees the Regulations to Protect Research Participants?
      • Is All Human Research Regulated?
      • Who is Responsible for Protecting Research Participants?
    • Additional Resources
    • Printable Information Materials
  • Upcoming Educational Events
  • Past Educational Events
  • Revised Common Rule
  • Human Research Protection Training
    • Human Research Protection Foundational Training
    • Participant-Centered Informed Consent Training
    • Considerations for Reviewing Human Subjects Research
    • OHRP Webinars
    • Mini-Tutorials
  • Videos
  • Exploratory Workshop
    • 2024 (Human Research with AI)
    • 2023 (Psychedelics Research)
    • 2022 (Payment for Participation)
    • 2021 (Third-Party Research Risks)
    • 2020 (Single IRB)
    • 2019 (Privacy and Data Research)
    • 2018 (Informed Consent)
  • Luminaries Lecture Series
  • Human Research Protection Program (HRPP) Resources
  • Educational Collaboration with OHRP
    • Research Community Forums (RCFs)
    • Educational Workshops
      • OHRP Co-Sponsored Workshops
    • Speaking Engagements
  • Education & Outreach Archived Materials

Exploring the Ethical and Practical Considerations of Psychedelics Research

Session III: Safeguarding Public Trust; Preventing Another Psychedelics Bubble

Watch Video

This discussion will cover how to further public trust in the potential use of psychedelics to treat mental health conditions. 

Speakers


Moderator: R. Cameron Wolf, Ph.D.
Senior Advisor, CSAP/Office of Prevention Innovation, DHHS/SAMHSA

R. Cameron Wolf, Ph.D.

Dr. R. Cameron Wolf serves as Senior Advisor at the Office for Prevention Innovation at DHHS/SAMHSA’s Center for Substance Abuse Prevention focusing on the expanding use of psychedelics, including emerging therapeutic use. He has a long history working to design, implement and evaluate programs targeted to vulnerable populations domestically and internationally. He holds a Master of Science from Harvard in Health and Social Behavior, and Ph.D. from Johns Hopkins in Social and Behavioral Science, supported through a National Research Service Award from the NIMH/Office of AIDS Research. He was Director of Prevention at AIDS Action Baltimore before beginning public service at HRSA’s HIV/AIDS Bureau in the Office of Science and Epidemiology in 2001. He supported global scale-up of PEPFAR’s HIV programs at USAID from 2003, including five years based in Thailand, and was USAID’s Lead Senior Advisor for Key Populations until 2022. He has published numerous articles, reports, and chapters.


Rosalind Watts, Ph.D.
Founder, ACER Integration

Dr. Watts will detail her journey as a psychotherapist whose position shifted from buying the psychedelics hype to being agnostic about the promising potential of using magic mushrooms to treat depression.

Rosalind Watts, Ph.D.

Dr. Watts is a clinical psychologist, a mother, and a nature lover. Her work as the Clinical Lead for Imperial College London’s psilocybin trial, and subsequent role as the Clinical Director at Synthesis Institute, have made her one of the most prominent voices and minds in the field of psychedelic research. Dr. Watts has been named as one of the 50 Most Influential People in Psychedelics as well as one of the top 16 Women Shaping the Future of Psychedelics. However, what sets Dr. Watts apart is her focus on integration, harm-reduction and inclusion in the psychedelic space. Dr. Watts builds tools and structures to foster connectedness after psychedelic experiences, finding inspiration for their design from nature. The most recent of which is the integration community she’s created - ACER Integration. ACER Integration aims to provide experiential education around how to integrate singular experiences into the wider collective and how to connect more deeply to the self, others, and nature.


Juliana Mercer
United States Marine Corps veteran, Political advocate in promoting safe access for veterans to MDMA and psychedelics for the treatment of PTSD

Ms. Mercer will provide perspectives as an advocate, a veteran who healed her PTSD with psychedelics, BOD for psychedelic veteran nonprofit, and coach to veterans pursuing psychedelic journeys in countries where they are not illegal.

Laura Sanders, Ph.D.

Juliana Mercer is a Marine Corps veteran who served her country honorably in and out of war zones for sixteen years. She deployed to Iraq and Afghanistan and spent five years providing holistic support to injured Marines recovering at the Wounded Warrior Battalion in San Diego. She has since channeled her passion and experience into the Veteran nonprofit arena, where she has supported Veteran transition and reintegration into civilian life. With over 20 years of experience working with and serving the veteran population, Juliana is deeply committed to supporting her brothers and sisters.

In her quest to help fellow veterans and herself heal from years of personal and military trauma, Juliana found relief through an FDA-designated breakthrough therapy that fundamentally changed her life. Thus, in her current role as Director of Public Policy for the nonprofit organization Healing Breakthrough, Juliana passionately advocates for the research, training, and deployment of system-wide adoption of MDMA-Assisted Therapy in the U.S. Department of Veterans Affairs.


Laura Sanders, Ph.D.
Senior Writer, Science News Magazine

Dr. Sanders will reflect on the role that media plays in reporting about psychedelics effects on mental illness and offer advice to scientists and policymakers on how to communicate with the public to combat misinformation.

Laura Sanders, Ph.D.

Laura Sanders is a senior writer at Science News magazine, where she focuses on neuroscience. She earned a Ph.D. in molecular biology from the University of Southern California in Los Angeles, where she studied neuronal fates in the developing fruit fly. She holds undergraduate degrees in creative writing and biology from Vanderbilt University in Nashville. Over nearly 15 years as a reporter, she has received awards recognizing editorial excellence for her column on child development, called Growth Curve, and multiple stories, including a series on consciousness, a feature article on the dearth of psychiatric drugs and an essay on brain changes caused by COVID-19.


Yuria Celidwen, Ph.D.
University of California, Berkeley, Department of Psychology and Othering & Belonging Institute

Dr. Celidwen will provide insight on how usage of psychedelics in western medical practices may impact the Indigenous peoples who originated psychedelic medicine and offer suggestions for relationship-building between the two groups.

Yuria Celidwen, Ph.D.

Yuria Celidwen, Ph.D., is of Indigenous Nahua and Maya descent from the highlands of Chiapas, Mexico. Her scholarship on Indigenous contemplation wide-reaching examines self-transcendence and its embodiment in prosocial behavior (ethics, compassion, kindness, awe, love, and sacredness). Her broader framework is the “ethics of belonging,” encouraging awareness, intention, and relational well-being and actions toward planetary flourishing through transdisciplinary approaches involving indigeneity, cultural psychology, and contemplative sciences for epistemological equity. Dr. Celidwen works for the United Nations with a concentration on Indigenous planetary health and sustainability. A Senior Fellow at the Other & Belonging Institute of the University of California, Berkeley, she bridges communities for a sense of belonging reclaiming, revitalizing, and transmitting Indigenous wisdom and advancing the rights of Indigenous Peoples and the rights of Nature. Dr. Celidwen co-chairs the Indigenous Religious Traditions Unit of the American Academy of Religion.


<< Session II: Considering Practical Aspects of Psychedelics Research

Top of page

Content created by Assistant Secretary for Health (ASH)
Content last reviewed September 21, 2023
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy